By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Viral vaccines > Comirnaty > Comirnaty Dosage
Viral vaccines
https://themeditary.com/dosage-information/comirnaty-dosage-2087.html

Comirnaty Dosage

Drug Detail:Comirnaty (Covid-19 vaccine, mrna)

Generic Name: TOZINAMERAN 0.225mg in 2.25mL

Dosage Form: injection, suspension

Drug Class: Viral vaccines

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

For intramuscular injection only.

​The storage, preparation, and administration information in this Prescribing Information apply to COMIRNATY supplied in:

•
​single dose vials with gray caps and labels with gray borders, and
•
​multiple dose vials with gray caps and labels with gray borders.

​COMIRNATY supplied in vials with gray caps and labels with gray borders MUST NOT be diluted prior to use.

Preparation for Administration

•
​COMIRNATY vials with gray caps and labels with gray borders contain a frozen suspension without preservative. Each vial must be thawed prior to administration. DO NOT DILUTE prior to use.
•
​Vials may be thawed in the refrigerator [2ºC to 8ºC (35ºF to 46ºF)] or at room temperature [up to 25ºC (77ºF)].
•
​Refer to thawing and preparation instructions in the panels below.
Preparation Instructions

COMIRNATY Vial with Gray Cap and Label with Gray Border –
Vial Verification

Image
•
Verify that the vial of COMIRNATY has a gray cap and a label with a gray border.

✔ Gray cap and label with gray border.

Thawing Prior to Use

Image
•
Thaw vial(s) of COMIRNATY before use either by:
o
Allowing vial(s) to thaw in the refrigerator [2°C to 8°C (35°F to 46°F)].
▪
A carton of 10 single dose vials may take up to 2 hours to thaw.
▪
A carton of 10 multiple dose vials may take up to 6 hours to thaw.
o
Allowing vial(s) to sit at room temperature [up to 25°C (77°F)] for 30 minutes.
•
Thawed vials can be stored in the refrigerator [2ºC to 8ºC (35ºF to 46ºF)] for up to 10 weeks prior to use.
•
Thawed vials may be stored at room temperature [up to 25°C (77°F)] for up to 12 hours prior to use.

Store in the refrigerator for up to 10 weeks prior to use.

Image
•
Before use, mix by inverting vaccine vial gently 10 times.
•
Do not shake.
•
Prior to mixing, the thawed vaccine may contain white to off-white opaque amorphous particles.
•
After mixing, the vaccine should appear as a white to off-white suspension with no visible particles.
•
Do not use if liquid is discolored or if particles are observed after mixing.

Gently × 10

Preparation of Individual 0.3 mL Doses

Image

Single Dose Vial

•
Withdraw a single 0.3 mL dose of COMIRNATY vaccine.
•
Administer immediately.
•
Discard vial and any excess volume.

Multiple Dose Vial

•
Multiple dose vials contain 6 doses of 0.3 mL each.
•
Withdraw 0.3 mL of COMIRNATY preferentially using low dead-volume syringes and/or needles. If standard syringes and needles are used, there may not be sufficient volume to extract 6 doses from a single vial.
•
Administer immediately.
•
If the amount of vaccine remaining in a multiple dose vial cannot provide a full dose of 0.3 mL, discard the vial and any excess volume.

Withdraw 0.3 mL dose of vaccine.

Multiple Dose Vial – Record Date and Time of First Puncture

Image
•
Record the date and time of first vial puncture on the COMIRNATY multiple dose vial label.
•
Store between 2°C to 25°C (35°F to 77°F).
•
Discard any unused vaccine 12 hours after first puncture.

Record the date and time of first puncture.
Use within 12 hours after first puncture.

Administration Information

​Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. The vaccine will be a white to off-white suspension. Do not administer if vaccine is discolored or contains particulate matter.

​After withdrawing a single 0.3 mL dose of COMIRNATY, administer immediately.

Vaccination Schedule

COMIRNATY is administered intramuscularly as a series of 2 doses (0.3 mL each) 3 weeks apart.

There are no data available on the interchangeability of COMIRNATY with COVID-19 vaccines from other manufacturers to complete the vaccination series. Individuals who have received 1 dose of COMIRNATY should receive a second dose of COMIRNATY to complete the vaccination series.

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by